Literature DB >> 17511629

Postprandial inflammation and endothelial dysfuction.

A Alipour1, J W F Elte, H C T van Zaanen, A P Rietveld, M Castro Cabezas.   

Abstract

Postprandial hyperlipidaemia is a common metabolic disturbance in atherosclerosis. During the postprandial phase, chylomicrons and their remnants can penetrate the intact endothelium and cause foam cell formation. These particles are highly atherogenic after modification. People in the Western world are non-fasting for most of the day, which consequently leads to a continuous challenge of the endothelium by atherogenic lipoproteins and their remnants. Furthermore, atherosclerosis is considered a low-grade chronic inflammatory disease. Many studies have shown that the process of atherogenesis in part starts with the interaction between the activated leucocytes and activated endothelium. Postprandial lipoproteins can activate leucocytes in the blood and up-regulate the expression of leucocyte adhesion molecules on the endothelium, facilitating adhesion and migration of inflammatory cells into the subendothelial space. Another inflammatory process associated with postprandial lipaemia is the activation of the complement system. Its central component C3 has been associated with obesity, coronary sclerosis, the metabolic syndrome and fasting and postprandial TAGs (triacylglycerols). Moreover, chylomicrons are the strongest stimulators of adipocyte C3 production via activation of the alternative complement cascade. A postprandial C3 increment has been shown in healthy subjects and in patients with CAD (coronary artery disease) and with FCHL (familial combined hyperlipidaemia). Postprandial lipaemia has been related to TAG and free fatty acid metabolism. All of these mechanisms provide an alternative explanation for the atherogenicity of the postprandial period.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511629     DOI: 10.1042/BST0350466

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  21 in total

Review 1.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Dietary macronutrient and energy intake and urinary incontinence in women.

Authors:  Nancy N Maserejian; Edward L Giovannucci; Kevin T McVary; Catherine McGrother; John B McKinlay
Journal:  Am J Epidemiol       Date:  2010-04-25       Impact factor: 4.897

3.  Dietary macronutrient intake and lower urinary tract symptoms in women.

Authors:  Nancy N Maserejian; Kevin T McVary; Edward L Giovannucci; John B McKinlay
Journal:  Ann Epidemiol       Date:  2011-03-21       Impact factor: 3.797

4.  Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans.

Authors:  K A Han; Y Patel; A A Lteif; R Chisholm; Kieren J Mather
Journal:  Diabetes Metab Res Rev       Date:  2011-05       Impact factor: 4.876

Review 5.  Obesity: a transgenerational problem linked to nutrition during pregnancy.

Authors:  Antonio E Frias; Kevin L Grove
Journal:  Semin Reprod Med       Date:  2012-10-16       Impact factor: 1.303

Review 6.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity.

Authors:  Amy R Johnson; J Justin Milner; Liza Makowski
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

7.  Genetic effects on postprandial variations of inflammatory markers in healthy individuals.

Authors:  Yu-Ching Cheng; Wen-Hong L Kao; Braxton D Mitchell; A Richey Sharrett; Kathleen A Ryan; Robert A Vogel; Alan R Shuldiner; Toni I Pollin
Journal:  Obesity (Silver Spring)       Date:  2009-11-12       Impact factor: 5.002

8.  Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.

Authors:  Giuseppe Derosa; Ilaria Ferrari; Angela D'Angelo; Sibilla A T Salvadeo; Elena Fogari; Alessia Gravina; Roberto Mereu; Ilaria Palumbo; Pamela Maffioli; Sabrina Randazzo; Arrigo F G Cicero
Journal:  Heart Vessels       Date:  2009-05-24       Impact factor: 2.037

9.  Serum Lipid Changes after Short Term SIPC Therapy for Lower Limb Lymphedema.

Authors:  Mostafa Mehrabi Bahar; Mohammad-Hadi Saeed Modaghegh; Ehsan Soltani
Journal:  Indian J Surg       Date:  2010-11-23       Impact factor: 0.656

10.  Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects.

Authors:  Lars Maegdefessel; Axel Schlitt; Susanna Pippig; Bernhard Schwaab; Kerstin Fingscheidt; Uwe Raaz; Michael Buerke; Harald Loppnow
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.